NCT02871648View on ClinicalTrials.gov

The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

December 31, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Placebo prepared by Investigation Drug Services at Brigham and Women's Hospital

DRUG

Fludrocortisone

Fludrocortisone 0.1 mg

DRUG

Eplerenone

Epleronone 100 mg

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT02871648 - The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production | Biotech Hunter | Biotech Hunter